CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
Probiotic +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02576197
NCT02576197N/ACompleted
CompareCT.gov

A Double Blind, Randomized, Placebo-Controlled Intervention Study to Evaluate the Effectiveness and Safety of a Treatment With a Probiotic in Adult Patients Diagnosed With Mild to Moderate Plaque Psoriasis

Biopolis S.L.·interventional·Posted Oct 15, 2015·Updated Oct 18, 2016

In Brief

A clinical study evaluating Probiotic and Placebo for Psoriasis. Completed, enrolled 98 participants across 1 site.

Detailed Summary

This study evaluates the efficiency of a probiotic as a coadjuvant in the conventional treatment of mild to moderate plaque psoriasis. Half of the patients will receive the probiotic per os, while the other half will receive a placebo; all patients will continue with their regular psoriasis treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesSpain
CollaboratorsKorott, S.L.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 15, 2015
Enrollment StartMay 1, 2015
Primary CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.7 years ago

Interventions

Probioticdietary

one capsule per day, containing the probiotic along with the patient's customary psoriasis treatment (excluding systemic treatments)

Placebodietary

one capsule per day, containing the placebo, along with the patient's customary psoriasis treatment (excluding systemic treatments)